Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125039122 | 12503912 | 2 | F | 20160615 | 20160629 | 20160628 | 20160706 | EXP | MX-009507513-1606MEX012333 | MERCK | 54.00 | YR | F | Y | 66.00000 | KG | 20160706 | CN | MX | MX |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125039122 | 12503912 | 1 | PS | PEGINTERFERON ALFA-2B | PEGINTERFERON ALFA-2B | 1 | Subcutaneous | 0.5 ML, QW (STRENGTH: 100 MCG) | 103949 | .5 | ML | POWDER FOR INJECTION | /wk | ||||||
125039122 | 12503912 | 2 | SS | COTRONAK | RIBAVIRIN | 1 | Oral | 200 MG, 5 TIMES PER DAY | 0 | 200 | MG | CAPSULE | |||||||
125039122 | 12503912 | 3 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Oral | 200 MG, PERMANET | U | 0 | 200 | MG | TABLET | ||||||
125039122 | 12503912 | 4 | C | VITAMIN B COMPLEX | CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX | 1 | Oral | 1 TABLET, FOR 1 MONTH | U | 0 | 1 | DF | TABLET | ||||||
125039122 | 12503912 | 5 | C | PLANTAGO ARENARIA | 2 | Oral | 2 SPOONS PRN | U | 0 | POWDER |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125039122 | 12503912 | 1 | Hepatitis C |
125039122 | 12503912 | 2 | Hepatitis C |
125039122 | 12503912 | 3 | Ascites |
125039122 | 12503912 | 4 | Vitamin supplementation |
125039122 | 12503912 | 5 | Constipation |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125039122 | 12503912 | OT |
125039122 | 12503912 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125039122 | 12503912 | Abdominal pain upper | |
125039122 | 12503912 | Arthralgia | |
125039122 | 12503912 | Asthenia | |
125039122 | 12503912 | Hepatic encephalopathy | |
125039122 | 12503912 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125039122 | 12503912 | 1 | 20160517 | 0 | ||
125039122 | 12503912 | 2 | 20160517 | 0 | ||
125039122 | 12503912 | 3 | 20160622 | 0 | ||
125039122 | 12503912 | 4 | 20160622 | 0 | ||
125039122 | 12503912 | 5 | 20160622 | 0 |